SCHEMBL9192560

SCHEMBL9192560

O=C(CBr)C(O)(CN1CCCCC1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 6/20 0.49
CHRM2 P08172 5/20 0.49
CHRM1 P11229 5/20 0.49
KCNH2 Q12809 4/20 0.49
HTR1A P08908 3/20 0.49
OPRM1 P35372 3/20 0.49
LMNA P02545 2/20 0.49
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
CHRM3 P20309 4/20 0.47
CHRM4 P08173 3/20 0.47
CHRM5 P08912 3/20 0.47
KDM4E B2RXH2 2/20 0.47
SIGMAR1 Q99720 2/20 0.47
DRD2 P14416 1/20 0.47
DRD1 P21728 1/20 0.47
HTR2A P28223 1/20 0.47
DRD3 P35462 1/20 0.47
SCN1A P35498 1/20 0.47
SCN2A Q99250 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9190061 0.81 CYP2D6 (0.51) CYP2D6CHRM2CHRM1KCNH2HTR1A
SCHEMBL6202673 0.80 KMT2A (0.50) CYP2D6CHRM2CHRM1KCNH2HTR1A
SCHEMBL11367108 0.78 KMT2A (0.47) CYP2D6CHRM2CHRM1KCNH2HTR1A
SCHEMBL9197055 0.78 ALDH1A1 (0.56) CYP2D6LMNAKMT2AMEN1SIGMAR1
Hydrochloric Acid SCHEMBL9197626 0.77 ALDH1A1 (0.59) CYP2D6LMNAKMT2AMEN1SIGMAR1
SCHEMBL8133327 0.76 CYP2D6 (0.45) CYP2D6CHRM2CHRM1KCNH2HTR1A
SCHEMBL8880422 0.75 CHRM2 (0.47) CYP2D6CHRM2CHRM1KCNH2HTR1A
SCHEMBL8570755 0.73 CHRM2 (0.66) CYP2D6CHRM2CHRM1KCNH2HTR1A
SCHEMBL14354524 0.72 CHRM2 (0.56) CYP2D6CHRM2CHRM1KCNH2HTR1A
SCHEMBL9192427 0.72 CYP2D6 (0.51) CYP2D6CHRM2CHRM1KCNH2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0486734-B1 1-Aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders MARION MERRELL DOW INC (US) 1995-08-30 EP disclosed
EP-0486734-A1 1-Aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders MARION MERRELL DOW INC. (US) 1992-05-27 EP disclosed
US-5001160-A 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders MARION LABORATORIES, INC. (US) 1991-03-19 US disclosed